Copyright (c) 2009 Yahoo! Inc. All rights reserved. http://news.yahoo.com/i/2367 science Biotechnology News en-us Fri, 20 Nov 2009 23:07:56 GMT 5 142 18 http://news.yahoo.com/i/2367 http://l.yimg.com/a/i/us/nws/th/main_142b.gif http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/us_stem_cells_nebraska ap/20091120/us_stem_cells_nebraska AP science Fri, 20 Nov 2009 23:07:56 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/us_stem_cells_nebraska"><img src="http://d.yimg.com/a/p/ap/20091120/capt.b4318e6683464d7480046fccabc251e4.stem_cells_nebraska_nebw101.jpg?x=130&y=103&q=85&sig=gJv4_aWY_lXjAkcch4kvyw--" align="left" height="103" width="130" alt="NU Board of Regent Jim McClurg of Lincoln, left, takes notes during public testimony Friday, Nov. 20, 2009, at the regent's monthly meeting in Lincoln, Neb., regarding the expansion or restriction of embryonic stem cell research as Regent Brad Bohn looks on. The University of Nebraska's governing board on Friday voted down a proposal to restrict the school's rules governing embryonic stem-cell research beyond what the federal government allows. (AP Photo/Bill Wolf)" border="0" /></a>AP - The University of Nebraska's governing board on Friday voted not to place tighter restrictions on embryonic stem cell research than those outlined under federal guidelines, which were expanded after President Barack Obama took office.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/us_stem_cells_nebraska"><img src="http://d.yimg.com/a/p/ap/20091120/capt.b4318e6683464d7480046fccabc251e4.stem_cells_nebraska_nebw101.jpg?x=130&y=103&q=85&sig=gJv4_aWY_lXjAkcch4kvyw--" align="left" height="103" width="130" alt="photo" title="NU Board of Regent Jim McClurg of Lincoln, left, takes notes during public testimony Friday, Nov. 20, 2009, at the regent's monthly meeting in Lincoln, Neb., regarding the expansion or restriction of embryonic stem cell research as Regent Brad Bohn looks on. The University of Nebraska's governing board on Friday voted down a proposal to restrict the school's rules governing embryonic stem-cell research beyond what the federal government allows. (AP Photo/Bill Wolf)" border="0"/></a></p><br clear="all"/> (AP) http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/hsn/20091120/hl_hsn/asthmacomboseemslessinfluencedbygenes hsn/20091120/asthmacomboseemslessinfluencedbygenes HealthDay health Fri, 20 Nov 2009 00:25:30 GMT HealthDay - THURSDAY, Nov. 19 (HealthDay News) -- People's genetic makeup has been shown to affect how they respond to asthma medications, but a new study finds that many people respond well to a particular combination treatment regardless of their genes. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/afp/20091119/hl_afp/healthmedicinestemcell afp/20091119/healthmedicinestemcell AFP health Thu, 19 Nov 2009 18:13:35 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/afp/20091119/hl_afp/healthmedicinestemcell"><img src="http://d.yimg.com/a/p/afp/20091119/capt.photo_1258654363242-1-0.jpg?x=130&y=86&q=85&sig=ZZoWqga5vy7Vlt58hEY66A--" align="left" height="86" width="130" alt="Stem cell cultures are held up at a lab. Embryonic stem cell therapy got a step closer to the clinic Thursday after US researchers said they filed a request for government approval of human trials.(AFP/Getty Images/File)" border="0" /></a>AFP - Embryonic stem cell therapy got a step closer to the clinic Thursday after US researchers said they filed a request for government approval of human trials.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/afp/20091119/hl_afp/healthmedicinestemcell"><img src="http://d.yimg.com/a/p/afp/20091119/capt.photo_1258654363242-1-0.jpg?x=130&y=86&q=85&sig=ZZoWqga5vy7Vlt58hEY66A--" align="left" height="86" width="130" alt="photo" title="Stem cell cultures are held up at a lab. Embryonic stem cell therapy got a step closer to the clinic Thursday after US researchers said they filed a request for government approval of human trials.(AFP/Getty Images/File)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091119/hl_nm/us_stemcells_eye nm/20091119/us_stemcells_eye Reuters health Thu, 19 Nov 2009 15:25:17 GMT Reuters - Advanced Cell Technology, a small Massachusetts-based biotechnology company, said on Thursday it has asked for approval to test human embryonic stem cells in treating a rare cause of blindness. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091119/hl_nm/us_actelion nm/20091119/us_actelion Reuters health Thu, 19 Nov 2009 07:59:36 GMT Reuters - Actelion Ltd, Europe's largest biotech company, said on Thursday the U.S. Food and Drug Administration (FDA) would review use of its drug Zavesca to treat a rare neurodegenerative disease early next year. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091118/sc_nm/us_madcow_gene nm/20091118/us_madcow_gene Reuters science Wed, 18 Nov 2009 23:21:47 GMT Reuters - Villagers in the highlands of Papua New Guinea who ritualistically ate human brains but did not die of a brain disease called kuru have a genetic mutation that protects them, researchers said Wednesday. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/hsn/20091118/hl_hsn/biotechsoybeansgoodsourceofomega3 hsn/20091118/biotechsoybeansgoodsourceofomega3 HealthDay health Wed, 18 Nov 2009 04:49:02 GMT HealthDay - TUESDAY, Nov. 17 (HealthDay News) -- Oil from genetically modified soybeans boosts levels of an important omega-3 fatty acid in the body, which may reduce the risk of heart attacks, U.S. researchers say. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/hsn/20091118/hl_hsn/stemcellsmayimproveheartbypassresults hsn/20091118/stemcellsmayimproveheartbypassresults HealthDay health Wed, 18 Nov 2009 04:48:57 GMT HealthDay - TUESDAY, Nov. 17 (HealthDay News) -- Patients who received bone marrow stem cell transplants during coronary bypass surgery (CABG) experienced "excellent long-term safety and survival," say German researchers, who also noted the first promising results for stem cell transplantation during mitral valve repair. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091117/hl_nm/us_decodegenetics nm/20091117/us_decodegenetics Reuters health Tue, 17 Nov 2009 20:01:28 GMT Reuters - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/afp/20091117/sc_afp/ustaiwanscienceprize afp/20091117/ustaiwanscienceprize AFP science Tue, 17 Nov 2009 19:19:33 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/afp/20091117/sc_afp/ustaiwanscienceprize"><img src="http://d.yimg.com/a/p/afp/20091117/capt.photo_1258485551734-1-0.jpg?x=130&y=83&q=85&sig=bBngk2VSiEuQgQgtGjvBmQ--" align="left" height="83" width="130" alt="A Taiwanese group has entered the running for the 10-million-dollar Archon X Prize for Genomics competition, the biggest medical prize in history, organizers said Tuesday. Cracker will take part in the international competition that aims to unearth new ways of rapid, cost-effective whole human genome sequencing.(Archon X Prize for Genomics)" border="0" /></a>AFP - A Taiwanese group has entered the running for the 10-million-dollar Archon X Prize for Genomics competition, the biggest medical prize in history, organizers said Tuesday.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/afp/20091117/sc_afp/ustaiwanscienceprize"><img src="http://d.yimg.com/a/p/afp/20091117/capt.photo_1258485551734-1-0.jpg?x=130&y=83&q=85&sig=bBngk2VSiEuQgQgtGjvBmQ--" align="left" height="83" width="130" alt="photo" title="A Taiwanese group has entered the running for the 10-million-dollar Archon X Prize for Genomics competition, the biggest medical prize in history, organizers said Tuesday. Cracker will take part in the international competition that aims to unearth new ways of rapid, cost-effective whole human genome sequencing.(Archon X Prize for Genomics)" border="0"/></a></p><br clear="all"/> (AFP) http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/mcclatchy/20091116/sc_mcclatchy/3358056 mcclatchy/20091116/3358056 McClatchy Newspapers science Mon, 16 Nov 2009 20:48:00 GMT McClatchy Newspapers - WASHINGTON &mdash; A whirlwind of activity is under way to apply the findings of the $3 billion Human Genome Project to improve health care in the United States and around the world. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091115/us_nm/us_genentech_lobbyists nm/20091115/us_genentech_lobbyists Reuters us Sun, 15 Nov 2009 19:15:59 GMT Reuters - Lobbyists working for biotech company Genentech wrote statements for more than a dozen lawmakers in the official record of the House debate on the health care bill, The New York Times reported on Sunday, citing e-mails. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091115/hl_nm/us_parkinsons nm/20091115/us_parkinsons Reuters health Sun, 15 Nov 2009 18:20:33 GMT Reuters - People of Japanese and European descent who have mutant versions of five genes may be at higher risk of developing Parkinson's disease, two large teams of researchers have found. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/20091113/ap_on_he_me/us_genzyme_drug_contamination ap/20091113/us_genzyme_drug_contamination AP health Fri, 13 Nov 2009 22:54:43 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/20091113/ap_on_he_me/us_genzyme_drug_contamination"><img src="http://d.yimg.com/a/p/ap/20091113/capt.718a537334e94c5ba49d77ebcb8a5e0c.genzyme_drug_contamination_nybz169.jpg?x=103&y=130&q=85&sig=eT2Xlre.CiJh5F39tgwB4g--" align="left" height="130" width="103" alt="FILE - In this May 28, 2008 file photo, Genzyme's Manufacturing Facility is seen, in the Allston neighborhood of Boston. Federal health regulators said Friday, Nov. 13, 2009, they have found tiny particles of trash in drugs made by biotechnology firm Genzyme. (AP Photo/Bizuayehu Tesfaye, file)" border="0" /></a>AP - Federal health regulators have found tiny particles of trash in drugs made by Genzyme, the second time this year the biotechnology company has been cited for contamination issues.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/ap/20091113/ap_on_he_me/us_genzyme_drug_contamination"><img src="http://d.yimg.com/a/p/ap/20091113/capt.718a537334e94c5ba49d77ebcb8a5e0c.genzyme_drug_contamination_nybz169.jpg?x=103&y=130&q=85&sig=eT2Xlre.CiJh5F39tgwB4g--" align="left" height="130" width="103" alt="photo" title="FILE - In this May 28, 2008 file photo, Genzyme's Manufacturing Facility is seen, in the Allston neighborhood of Boston. Federal health regulators said Friday, Nov. 13, 2009, they have found tiny particles of trash in drugs made by biotechnology firm Genzyme. (AP Photo/Bizuayehu Tesfaye, file)" border="0"/></a></p><br clear="all"/> (AP) http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091113/sc_nm/us_food_cloning nm/20091113/us_food_cloning Reuters science Fri, 13 Nov 2009 12:38:58 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091113/sc_nm/us_food_cloning"><img src="http://d.yimg.com/a/p/rids/20091113/i/r1912987869.jpg?x=130&y=86&q=85&sig=ILRqInsmqgnQZfr_Qkk_hg--" align="left" height="86" width="130" alt="K.C., the first animal produced by cloning from a cell taken from a carcass, in an undated photo courtesy of the genomics services company Viagen. REUTERS/Candace Dobson/Viagen/Handout" border="0" /></a>Reuters - To the untrained eye, Pollard Farms looks much like any other cattle ranch. Similar looking cows are huddled in similar looking pens. But some of the cattle here don't just resemble each other. They are literally identical -- clear down to their genes.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091113/sc_nm/us_food_cloning"><img src="http://d.yimg.com/a/p/rids/20091113/i/r1912987869.jpg?x=130&y=86&q=85&sig=ILRqInsmqgnQZfr_Qkk_hg--" align="left" height="86" width="130" alt="photo" title="K.C., the first animal produced by cloning from a cell taken from a carcass, in an undated photo courtesy of the genomics services company Viagen. REUTERS/Candace Dobson/Viagen/Handout" border="0"/></a></p><br clear="all"/> (Reuters) http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/hsn/20091113/hl_hsn/genetherapybringsnewmuscletomonkeys hsn/20091113/genetherapybringsnewmuscletomonkeys HealthDay health Fri, 13 Nov 2009 04:49:44 GMT HealthDay - THURSDAY, Nov. 12 (HealthDay News) -- Researchers are reporting that injections of genes into the leg muscles of monkeys helped the animals gain muscle size and strength without side effects. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091111/sc_nm/us_genetherapy_muscles nm/20091111/us_genetherapy_muscles Reuters science Wed, 11 Nov 2009 19:42:45 GMT Reuters - A gene therapy treatment that stops the breakdown of muscle appeared safe in monkeys and may build up muscle, too, researchers reported on Wednesday. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091111/sc_nm/us_humans_speech nm/20091111/us_humans_speech Reuters science Wed, 11 Nov 2009 19:12:56 GMT <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091111/sc_nm/us_humans_speech"><img src="http://d.yimg.com/a/p/rids/20091111/i/r2651349098.jpg?x=130&y=87&q=85&sig=n45ZMLzd087iVGemNWrtdQ--" align="left" height="87" width="130" alt="Pedro the Chimpanzee sits in his enclosure in Berlin Zoo, June 9, 2009. REUTERS/Fabrizio Bensch" border="0" /></a>Reuters - Why can humans talk and chimps cannot? Researchers said on Wednesday they have another clue and it lies not simply in the genetic code, but in how the genes function.</p><br clear="all"/> <p><a href="http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091111/sc_nm/us_humans_speech"><img src="http://d.yimg.com/a/p/rids/20091111/i/r2651349098.jpg?x=130&y=87&q=85&sig=n45ZMLzd087iVGemNWrtdQ--" align="left" height="87" width="130" alt="photo" title="Pedro the Chimpanzee sits in his enclosure in Berlin Zoo, June 9, 2009. REUTERS/Fabrizio Bensch" border="0"/></a></p><br clear="all"/> (Reuters) http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/nm/20091110/sc_nm/us_science_animal_human nm/20091110/us_science_animal_human Reuters science Tue, 10 Nov 2009 00:06:28 GMT Reuters - A mouse that can speak? A monkey with Down's Syndrome? Dogs with human hands or feet? British scientists want to know if such experiments are acceptable, or if they go too far in the name of medical research. http://us.rd.yahoo.com/dailynews/rss/biotech/*http://news.yahoo.com/s/hsn/20091106/hl_hsn/genetherapyforfatalbraindisorderjustthebeginning hsn/20091106/genetherapyforfatalbraindisorderjustthebeginning HealthDay health Fri, 06 Nov 2009 04:48:51 GMT HealthDay - THURSDAY, Nov. 5 (HealthDay News) -- The reported success of gene therapy in treating two children with adrenoleukodystrophy (ALD) brings hope to patients with the potentially crippling and fatal brain disorder and their families, says a nonprofit group that supports ALD research.